Orionis Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Orionis Biosciences's estimated annual revenue is currently $10.4M per year.
- Orionis Biosciences's estimated revenue per employee is $155,000
Employee Data
- Orionis Biosciences has 67 Employees.
- Orionis Biosciences grew their employee count by 6% last year.
Orionis Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President and CEO | Reveal Email/Phone |
2 | Chief Data Scientist | Reveal Email/Phone |
3 | VP, Technical Operations | Reveal Email/Phone |
4 | VP, Chemistry | Reveal Email/Phone |
5 | VP Finance | Reveal Email/Phone |
6 | Director, Translational Biology at Orionis Biosciences | Reveal Email/Phone |
7 | Director Biology | Reveal Email/Phone |
8 | Director Biology | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Senior Program Manager | Reveal Email/Phone |
Orionis Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Orionis Biosciences?
Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities. Our technologies and pipeline include proprietary A-Kineâ„¢ biologics and Allo-Glueâ„¢ small molecule platforms with broad, innovative applications to the reprogramming of disease states. The company is currently advancing multiple novel immunotherapies for the treatment of cancer.
keywords:N/A
N/A
Total Funding
67
Number of Employees
$10.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Orionis Biosciences News
2022-04-06 - Global Targeted Protein Degradation (TPD) Market Landscape ...
... Monte Rosa Therapeutics; NeoImmuneTech; Novartis; Nurix Therapeutics; Origami Therapeutics; Orionis Biosciences; Orum Therapeutics...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.4M | 67 | N/A | N/A |
#2 | N/A | 68 | 48% | N/A |
#3 | N/A | 68 | -11% | N/A |
#4 | $13.9M | 69 | 33% | N/A |
#5 | $9M | 69 | 25% | N/A |